Ulcerative Colitis:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Ulcerative Colitis Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Ulcerative Colitis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Ulcerative Colitis 24
Subjects Recruited Over a Period of Time 30
Prominent Sponsors 31
Top Companies Participating in Ulcerative Colitis Therapeutics Clinical Trials 33
Prominent Drug Comparison 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
Salix Pharmaceuticals Ltd. 37
Clinical Trial Overview of Salix Pharmaceuticals Ltd. 37
Shire Plc 38
Clinical Trial Overview of Shire Plc 38
Zeria Pharmaceutical Co Ltd 39
Clinical Trial Overview of Zeria Pharmaceutical Co Ltd 39
Ferring Pharmaceuticals, Inc. 40
Clinical Trial Overview of Ferring Pharmaceuticals, Inc. 40
AbbVie Inc. 41
Clinical Trial Overview of AbbVie Inc. 41
Dr. Falk Pharma GmbH 42
Clinical Trial Overview of Dr. Falk Pharma GmbH 42
Johnson & Johnson 43
Clinical Trial Overview of Johnson & Johnson 43
GlaxoSmithKline plc 44
Clinical Trial Overview of GlaxoSmithKline plc 44
Isis Pharmaceuticals, Inc. 45
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 45
Santarus, Inc. 46
Clinical Trial Overview of Santarus, Inc. 46
Warner Chilcott Plc 47
Clinical Trial Overview of Warner Chilcott Plc 47
Tillotts Pharma AG 48
Clinical Trial Overview of Tillotts Pharma AG 48
Merck & Co., Inc. 49
Clinical Trial Overview of Merck & Co., Inc. 49
Bristol-Myers Squibb Company 50
Clinical Trial Overview of Bristol-Myers Squibb Company 50
Millennium Pharmaceuticals, Inc. 51
Clinical Trial Overview of Millennium Pharmaceuticals, Inc. 51
Warner Chilcott Company, Inc. 52
Clinical Trial Overview of Warner Chilcott Company, Inc. 52
Am-Pharma B.V. 53
Clinical Trial Overview of Am-Pharma B.V. 53
Otsuka Holdings Co., Ltd. 54
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 54
Ajinomoto Pharmaceuticals Co., Ltd. 55
Clinical Trial Overview of Ajinomoto Pharmaceuticals Co., Ltd. 55
Clinical Trial Overview of Top Institutes / Government 56
Keio University 56
Clinical Trial Overview of Keio University 56
Hyogo College Of Medicine 57
Clinical Trial Overview of Hyogo College Of Medicine 57
Academic Medical Centre 58
Clinical Trial Overview of Academic Medical Centre 58
Saitama Medical University 59
Clinical Trial Overview of Saitama Medical University 59
Tokyo Medical and Dental University 60
Clinical Trial Overview of Tokyo Medical and Dental University 60
Vanderbilt University 61
Clinical Trial Overview of Vanderbilt University 61
University of Washington 62
Clinical Trial Overview of University of Washington 62
Kyoto University 63
Clinical Trial Overview of Kyoto University 63
University Hospitals of Leicester NHS Trust 64
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 64
VU University Medical Center 65
Clinical Trial Overview of VU University Medical Center 65
Boston Children’s Hospital 66
Clinical Trial Overview of Boston Children’s Hospital 66
University of Heidelberg 67
Clinical Trial Overview of University of Heidelberg 67
Indiana University 68
Clinical Trial Overview of Indiana University 68
University Hospitals of Cleveland 69
Clinical Trial Overview of University Hospitals of Cleveland 69
University of Pittsburgh 70
Clinical Trial Overview of University of Pittsburgh 70
Hvidovre University Hospital 71
Clinical Trial Overview of Hvidovre University Hospital 71
The Medical University of Graz 72
Clinical Trial Overview of The Medical University of Graz 72
Asan Medical Center 73
Clinical Trial Overview of Asan Medical Center 73
Postgraduate Institute of Medical Education and Research 74
Clinical Trial Overview of Postgraduate Institute of Medical Education and Research 74
The University of Chicago 75
Clinical Trial Overview of The University of Chicago 75
Five Key Clinical Profiles 76
Appendix 160
Abbreviations 160
Definitions 160
Research Methodology 161
Secondary Research 161
About GlobalData 162
Contact Us 162
Disclaimer 162
Source 163


【レポート販売概要】

■ タイトル:Ulcerative Colitis:グローバル臨床試験レビューH2, 2013
■ 英文:Ulcerative Colitis Global Clinical Trials Review, H2, 2013
■ 発行日:2013年9月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162308
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。